Full Text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Iodine is an essential element for growth and development of children. Ensuring adequate iodine intake and monitoring iodine intake are important public health concerns. According to the World Health Organization, a population-based assessment of iodine status is often done by measuring urine iodine concentration (UIC) in children aged 6–12 years. National data for large countries may hide regional differences in the UIC. Currently, there is limited data on the iodine status of children in Russia. We summarized the evidence on the iodine status of children in Russia using both international and local literature in accordance with the PRISMA guidelines. A total of 2164 studies were identified, 12 of which met the selection criteria and covered 10 of 85 federal subjects. For most of the Russian regions there was no information on UIC. A range of methodologies were used to determine UIC. The median UIC ranged from 46 μg/L in the mountainous areas in the Republic of Kabardino-Balkaria, which corresponds to a moderate iodine deficiency (ID), to 719 μg/L in the town of Turinsk (Sverdlovsk region) indicating excessive of iodine intake. Nationwide monitoring should be implemented in Russia and public health measures should be adjusted to regional and local conditions to ensure adequate iodine nutrition for all citizens.

Details

Title
Iodine Status of 6–12-Year-Old Children in Russia over the Past 10 Years: A Scoping Review
Author
Korobitsyna, Rimma 1   VIAFID ORCID Logo  ; Aksenov, Andrey 1   VIAFID ORCID Logo  ; Sorokina, Tatiana 1   VIAFID ORCID Logo  ; Trofimova, Anna 1   VIAFID ORCID Logo  ; Grjibovski, Andrej M 2   VIAFID ORCID Logo 

 Arctic Biomonitoring Laboratory, Northern (Arctic) Federal University named after M. V. Lomonosov, Naberezhnaya Severnoy Dvini 17, 163002 Arkhangelsk, Russia; [email protected] (A.A.); [email protected] (T.S.); [email protected] (A.T.); [email protected] (A.M.G.) 
 Arctic Biomonitoring Laboratory, Northern (Arctic) Federal University named after M. V. Lomonosov, Naberezhnaya Severnoy Dvini 17, 163002 Arkhangelsk, Russia; [email protected] (A.A.); [email protected] (T.S.); [email protected] (A.T.); [email protected] (A.M.G.); Central Scientific Research Laboratory, Northern State Medical University, Troitskiy Ave. 51, 163000 Arkhangelsk, Russia; West Kazakhstan Marat Ospanov Medical University, Aktobe 030019, Kazakhstan; Department of Epidemiology and Modern Vaccination Technologies, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia 
First page
897
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20726643
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2633034961
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.